TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04912492

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: RealConsent1.0
Description: A web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: RealConsent1.0
Description: A web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RealConsent2.0
Description: A revised and updated web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors, but also integrates new program segments into RealConsent 1.0 specific to how alcohol use can inhibit SV intervention at multiple steps of the decision-making process.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RealConsent2.0
Description: A revised and updated web-based multi-media sexual violence prevention program that enhances knowledge and skills for effective consent for sex and for prosocial bystander behaviors, but also integrates new program segments into RealConsent 1.0 specific to how alcohol use can inhibit SV intervention at multiple steps of the decision-making process.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress Management
Description: A web-based multimedia program designed to help individuals recognize the symptoms and sources of stress and provide them with a wide variety of powerful tools for managing stress.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress Management
Description: A web-based multimedia program designed to help individuals recognize the symptoms and sources of stress and provide them with a wide variety of powerful tools for managing stress.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol intoxication
Description: Men assigned to moderate alcohol dose condition (target BrAC .08%) with NIAAA approved alcohol administration procedures

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcohol intoxication
Description: Men assigned to moderate alcohol dose condition (target BrAC .08%) with NIAAA approved alcohol administration procedures

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol intoxication
Description: Men assigned to moderate alcohol dose condition (target BrAC .08%) with NIAAA approved alcohol administration procedures

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No-Alcohol Placebo
Description: Men assigned to an no-alcohol placebo control condition.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No-Alcohol Placebo
Description: Men assigned to an no-alcohol placebo control condition.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No-Alcohol Placebo
Description: Men assigned to an no-alcohol placebo control condition.
Study: NCT02933398

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic Assisted Nephrectomy
Description: Robotic (Davinci)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic Assisted Nephrectomy
Description: Regular Laparoscopic Technique.
Study: NCT05324449

Intervention type: DRUG
Group type: OTHER
Intervention: Cannabidiol 100 MG/ML
Description: pharmaceutical grade cannabidiol
Study: NCT06603571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3841136
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tirzepatide
Description: Administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study: NCT06588283

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC.
Study: NCT06360094

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1839100
Description: BI 1839100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1839100
Description: BI 1839100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1839100
Description: BI 1839100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1839100
Description: BI 1839100

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06085664

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5678
Description: Given by IV (vein)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piflufolastat F18
Description: Given by IV (vein)
Study: NCT05757791

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: The full duration of therapy will be six-weeks. The route of administration will be oral. The starting dose of the medication will be 10mg daily for the first 14 days of the study, with a dose escalation to 25mg for the last 28 days of the study.
Study: NCT06667232

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single-pulse stimulation
Description: Investigators use single-pulse electrical stimulations at 1Hz to elicit cortico-cortical evoked potentials

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Paired-pulse stimulation
Description: The repetitive delivery of pairs of stimulation pulses is DES patten with a 5-50 ms interval between each pulse, constitutes repetitive paired-pulse stimulation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stepwise frequency stimulation
Description: Stepwise incremental stimulation ranging from 5 Hz to 145 Hz following a cyclic pattern.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Burst stimulation
Description: Burst stimulation pattern consisting of short bursts delivered once a second and an intraburst frequency of 50 Hz, 100 Hz, 150 Hz, 175 Hz and 200 Hz
Study: NCT06610448

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ABPMPro
Description: This is an upper arm, cuff-based intermittent ambulatory BP device. This device has an internal activity and body position sensor which gathers information about sleep-wake estimation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spacelabs Ambulatory Blood Pressure Monitoring
Description: This is an upper arm cuff-based device with tubing for continuous ambulatory BP monitoring with a unique activity sensor that correlate with patient movement activity with blood pressure changes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aktiia Blood Pressure
Description: This is a wrist cuff-based device which uses an optical sensor (photoplethysmography sensor) to gather data from the arteries under the skin surface. Aktiia has an upper arm cuff device which is used for calibration once every month to provide a baseline blood pressure reading.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aktiia Blood Pressure
Description: This is a wrist cuff-based device which uses an optical sensor (photoplethysmography sensor) to gather data from the arteries under the skin surface. Aktiia has an upper arm cuff device which is used for calibration once every month to provide a baseline blood pressure reading.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiveMetric
Description: This is a wrist cuff-based applanation tonometry continuous ambulatory BP device. This device has automatic self-calibration and comes in various sizes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiveMetric
Description: This is a wrist cuff-based applanation tonometry continuous ambulatory BP device. This device has automatic self-calibration and comes in various sizes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bpro
Description: This is a wrist cuff-based wireless oscillometric, continuous ambulatory BP device. It has applanation tonometry at the wrist with Pulse wave analysis. This device needs calibration with a brachial cuff BP measurement.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bpro
Description: This is a wrist cuff-based wireless oscillometric, continuous ambulatory BP device. It has applanation tonometry at the wrist with Pulse wave analysis. This device needs calibration with a brachial cuff BP measurement.
Study: NCT06134076

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unfermented chickpea
Description: Frozen meals containing 100 g unfermented chickpeas
Study: NCT06367946

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.

Intervention type: PROCEDURE
Intervention: mechanical ventilation
Description: Mechanical ventilation is machine-delivered flow of gases to both oxygenate and ventilate a patient who is unable to maintain physiological gas exchange.
Study: NCT06149572

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lateral position procedure
Description: Lateral positioning will be used as an intervention for spinal hypotension.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sitting position porocedure
Description: parturients will get spinal punctures in the sitting position
Study: NCT06523049

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vorolanib Tablets
Description: Multi-targeted receptor tyrosine kinase inhibitor with potent inhibition of VEGFR2, KIT, PDGFR, FLT3 and RET, exerting anti-tumor effects mainly through inhibition of neovascularization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab Injection
Description: Recombinant human-derived immunoglobulin G (IgG4)-type anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, by binding to PD-1 and blocking PD-1 binding to PD-L1 and PD-L2, disarms the immunosuppressive effect, activates T-cell function, and enhances T-cell immunosurveillance and killing ability against tumors to generate tumor immune response.
Study: NCT04332068

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ivermectin
Description: Ivermectin (NT007) 3 mg tablets are round, white, and scored on one side. Ivermentin 3mg tablets will be crushed and mixed thoroughly in 10mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ivermectin
Description: Ivermectin (NT007) 3 mg tablets are round, white, and scored on one side. Ivermentin 3mg tablets will be crushed and mixed thoroughly in 10mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral ivermectin
Description: Ivermectin (NT007) 3 mg tablets are round, white, and scored on one side. Ivermentin 3mg tablets will be crushed and mixed thoroughly in 10mL of water.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Permethrin Cream
Description: permethrin cream 5% (Pioletal® Plus) is a white coloured lotion with a homogenous appearance and an odour of fennel and lavender.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo tablet
Description: placebo tablets are round, white, scored on one side. There are no active substances in the placebo tablets.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo cream
Description: A placebo cream is a white coloured lotion with a homogenous appearance and an odour of fennel and lavender but lacking the permethrin agent.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo cream
Description: A placebo cream is a white coloured lotion with a homogenous appearance and an odour of fennel and lavender but lacking the permethrin agent.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo cream
Description: A placebo cream is a white coloured lotion with a homogenous appearance and an odour of fennel and lavender but lacking the permethrin agent.
Study: NCT05341778

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shoulder bridge
Description: The shoulder bridge is great for, strengthening your gluteal muscles, quadriceps, hamstrings, pelvic floor, abdominals and back muscles; most notably the tiny ones which control movement of each individual vertebrae and can weaken after episodes of back pain.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clam shell
Description: Scissors is an abdominal exercise that strengthens the transverse abdominals, helping flatten your belly and strengthen your entire core. Scissors is not only a core strength move, but it is also a great stretch for your hamstrings and your lower back.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clam shell
Description: Scissors is an abdominal exercise that strengthens the transverse abdominals, helping flatten your belly and strengthen your entire core. Scissors is not only a core strength move, but it is also a great stretch for your hamstrings and your lower back.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scissors
Description: Scissors is an abdominal exercise that strengthens the transverse abdominals, helping flatten your belly and strengthen your entire core. Scissors is not only a core strength move, but it is also a great stretch for your hamstrings and your lower back.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Adductor squeeze
Description: Adductor Squeeze exercise The SQ exercise is an isometric hip adduction exercise with the player holding a ball between their knees.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adductor squeeze
Description: Adductor Squeeze exercise The SQ exercise is an isometric hip adduction exercise with the player holding a ball between their knees.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic clock supine
Description: The pelvic clock is a brilliant exercise to help achieve flexibility and strength in the lower back, pelvic floor, and core-in order to prevent pain and injury.
Study: NCT06134076

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fermented chickpea
Description: Frozen meals containing 100 g fermented chickpeas
Study: NCT06668961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B001
Description: Administration by intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B001
Description: Administration by intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B003
Description: Administration by intravenous infusion
Study: NCT06433752

Intervention type: OTHER
Intervention: No Intervention
Description: No Intervention
Study: NCT06541379

Intervention type: OTHER
Intervention: No intervention

Intervention type: OTHER
Intervention: No intervention
Study: NCT06672445

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARO-ATXN2 Injection
Description: single dose of ARO-ATXN2 by intrathecal (IT) administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: calculated volume to match active treatment by IT administration
Study: NCT06616194

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant
Description: Rimegepant 75 mg orally disintegrating tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo oral disintegrating tablets
Study: NCT06615986

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cardiosyn
Description: Two sachets by mouth daily. Each dose (sachet) is 8.1 grams. For 2 doses it will be 16.2 grams per person per day.
Study: NCT06611618

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle power assessment
Description: Isokinetic dynamometry test Stair ascent/descent on instrumented stairs
Study: NCT05341778

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: urine hold and tummy tuck in
Description: During tummy tuck patients are able to strategically tighten and reinforce the muscles around the pelvic floor, urethra, and other structures. This increased strength and support greatly reduces stress urinary incontinence

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bridging
Description: A bridge exercise isolates and strengthens your gluteus (butt) muscles - the gluteus maximus, medius and minimus - and hamstrings, which are the main muscles that make up the posterior chain. It is done by lying on your back with your knees bent, feet flat on the ground and at a comfortable distance from your butt.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Split table top
Description: To strengthen your abs, shoulders, arms and legs. The most important part of this move is to contract your abs fully before you start to lower your hips

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electrical muscle stimulation
Description: Electric stimulation works by mimicking the natural way by which the body exercises its muscles. The electrodes attached to the skin deliver impulses that make the muscles contract. It is beneficial in increasing the patient's range of motion and improves the circulation of the body.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Description: Electric stimulation works by mimicking the natural way by which the body exercises its muscles. The electrodes attached to the skin deliver impulses that make the muscles contract. It is beneficial in increasing the patient's range of motion and improves the circulation of the body.
Study: NCT06173388

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structured exercise training program + The swallow resistance exercise program.
Description: Structured exercise training program + The swallow resistance exercise program.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Only the swallow resistance exercise program.
Description: Only the swallow resistance exercise program.

Intervention type: OTHER
Group type: OTHER
Intervention: Only the swallow resistance exercise program.
Description: Only the swallow resistance exercise program.
Study: NCT06324643

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sensory motor integration training
Description: one group treated by strengthening exercises , stretching ,and occupational therapy and other group treated by strengthening exercises , stretching ,and occupational therapy and sensory motor integration training

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sensory motor integration training
Description: one group treated by strengthening exercises , stretching ,and occupational therapy and other group treated by strengthening exercises , stretching ,and occupational therapy and sensory motor integration training
Study: NCT05290948

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravitreal injection of bevacizumab with acetazolamide tablets
Description: intravitreal injection of bevacizumab with acetazolamide tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravitreal injection of bevacizumab
Description: intravitreal injection of bevacizumab
Study: NCT04964661

Intervention type: OTHER
Intervention: Medical Imaging
Description: MRI imaging
Study: NCT04871152

Intervention type: DRUG
Intervention: OnabotulinumtoxinA
Description: To compare the effectiveness of triptans before and after initiation of treatment with OnabotuliumtoxinA.
Study: NCT05987826

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib 80mg QD oral 8 weeks.
Study: NCT05572021

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Propspective VHR with Fortiva
Description: Ventral hernia repair using Fortiva biologic mesh

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RetroSpective VHR with Strattice
Description: Retrospective cohort of ventral hernia repair patients using Strattice mesh
Study: NCT05556980

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: totally laparoscopic distal gastrectomy
Description: all the surgical procedure would be finished under laparoscopy
Study: NCT04633226

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V114
Description: 15-valent pneumococcal conjugate vaccine (PCV) containing 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) present in Prevnar 13™ plus 2 additional serotypes (22F, 33F) in each 0.5 mL sterile suspension for intramuscular injection.
Study: NCT05854485

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group
Description: Participants in this group will receive multi-muscle FES during arm robotic training

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Robot only group
Description: Participants in this group will receive arm robotic training only